Michael Lahn

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

Alba A. Brandes, Santosh Kesari, Juan Manuel Sepúlveda-Sánchez et al. · Neuro-Oncology · 2016 · 264 citations · Full text

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla et al. · British Journal of Cancer · 2018 · 262 citations · Full text

Immunoregulatory Functions of γδ T Cells

Willi K. Born, Carol Cady, Jessica Jones‐Carson et al. · Advances in immunology · 1998 · 197 citations

γδ T Cells, Adaptive Immune System, Immune Regulation +7

Negative regulation of airway responsiveness that is dependent on γδ T cells and independent of αβ T cells

Michael Lahn, Arihiko Kanehiro, Katsuyuki Takeda et al. · Nature Medicine · 1999 · 175 citations

γδ T Cells, Lung Inflammation, Cell Signaling +11

Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Luis Paz‐Ares, Jean‐Yves Douillard, P. Koralewski et al. · Journal of Clinical Oncology · 2006 · 155 citations